{
  "report_rows": [
    {
      "kpi": "Non-GAAP EPS",
      "prediction": "MISS",
      "answer": "pred ~$2.72 vs. cons $2.78",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "MISS",
      "answer": "pred ~-1.8% vs. cons -0.7%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "DSA net book-to-bill",
      "prediction": "MISS",
      "answer": "pred ~0.97x vs. cons 1.02x",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 non-GAAP EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$10.85 vs. cons $11.05 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 organic revenue growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~-1.5% vs. cons -0.8% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 operating-margin expansion",
      "prediction": "LOWER",
      "answer": "guide ~120 bps vs. cons 135 bps (FY26)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -7.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -10.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A ~-1.1-point organic-growth shortfall versus consensus and a ~$0.20 FY26 EPS-guide gap imply that the assumed 2H revenue/margin acceleration shifts later, pulling 2026 and 2027 estimates lower even after investors credit the portfolio-margin actions.",
  "day5_confidence": "MEDIUM"
}